We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Northw.Bio Di | NWBT | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
15.00 | 15.00 |
Top Posts |
---|
Posted at 10/10/2007 14:02 by kozel NWBT have developed the world's first therapeutic vaccine for Brain Cancer, DCVax(R)-Brain, which is commercially available to patients in Switzerland. Clinical trial data has shown that the vaccine delays disease recurrence by nearly 3-fold, from 6.9 months to 18.1 months for newly diagnosed patients, and also extends these patients' survival from 14.6 months to more than 33 months. |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions